Resultados del sistema Paradigm Real Time 722® en una serie de pacientes con diabetes mellitus tipo I

RT-CGM use close to 20 per cent with PRT-722 dual system was associated with a reduction of HbA1C levels, less severe hypoglycaemias and improvement of DQOL in T1DM patients at 3 and 12 months.